cyrus vincent
Feb 5, 2018

Can Post-Filing Evidence be used to Invalidate a Patent?

This past October, in Amgen v. Sanofi (Fed. Cir. 2017), the Federal Circuit sent shivers down the spine of the biotechnology industry when it overturned a district court decision confirming the validity of two patents that claim antibodies for lowering cholesterol.

http://bit.ly/2E3MunQ